Panbela Therapeutics's total assets for Q2 2024 were $9.41M, a decrease of -10.57% from the previous quarter. PBLA total liabilities were $19.98M for the fiscal quarter, a 45.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.